The results of genetic differential analysis indicated that the expression of the ACBD3-AS1 gene was higher in the high-risk group in our model in gastric cancer, which further confirmed that ACBD3-AS1 may be an oncogene in GC. This evidence concerns the gene ACBD3 and gastric cancer.